Compound 42 presented proapoptotic effects in cancer cell lines, inducing cell cycle arrest at the G0/G1 phase, increased p21 and BAX, and decreased BCL-2 antiapoptotic proteins [108,167]. Here, BCL2 is linked to cancer.